S3B

Stockholm3 – Biopsy cutoff

PublishedAugust 14, 2024

Biopsy cutoff is the threshold value in the Stockholm3 test risk score that determines whether a man should be further investigated for prostate cancer, in which case this is done, for example, with magnetic resonance imaging (MRI) or prostate biopsy.

💜 We celebrate Mother's Day. Get 10% off with the code: MAMMA Health checks for increased well-being

Go to the campaign Browse healthchecks
Where is the cutoff?

In Swedish guidelines, the cutoff value is set at:

  • Over 11% – risk of clinically significant prostate cancer (Gleason ≥7)

This means that if your Stockholm3 risk score is over 11%, further investigation is recommended according to national guidelines.

Why is the cutoff important?

The cutoff value of 11% is scientifically established based on clinical studies to balance:

  • High detection of dangerous cancer
  • Low proportion of unnecessary biopsies
Clinical use

The biopsy cutoff result is used as a clear decision support in primary care. What is often referred to as the “Biopsy Cutoff” in medical reports is precisely this 11% limit.

Remember: Your risk score should always be interpreted in consultation with a doctor, along with other factors such as age, family history and imaging diagnostics.

Written by: The team at Testmottagningen.se